Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...

Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...

Chronic pain affects more than 50 million Americans, yet for decades, treatment options for pain that persists in the absence ...

Whether you’re dealing with a chronic condition, neuropathy or a sudden illness, it’s important to seek help, and not just live with pain. Allendale Acupuncture & ...

Analyzing molecular changes in two types of peripheral nerves that are affected in diabetic peripheral neuropathy – the sural ...

Neuropathy may be an early symptom of ATTR-CM. Explore treatments and lifestyle tips that may help you maintain or improve ...

Diabetic neuropathy is a common, progressive complication of diabetes characterized by nerve damage that leads to chronic ...

Explore comprehensive treatments for CIDP, including corticosteroids, plasma exchange, immunoglobulin therapy, and others.

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process could help improve recovery after nerve injury and reduce chronic pain.

RICHMOND, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast ...